Dear Friend: Welcome to our forum; which has now become your forum. You
will meet many wonderful people who know and understand the cancer journey.
I have attached links to help you better understand this form of cancer and
good luck. Your friend, lillian
http://iris.nyit.edu/~babraham/1styear/pharm/antineoplastics.html USED FOR
CANCER THERAPY
http://www.askjeves.com/main/askjeeves.asp?ask=myelofibrosis%3F&origin=&site
_name=Jeeves&metasearch=yes&x=19&y=17
Warmly, lillian
We invite you to take a look at our Album.
www.angelfire.com/sc/molangels/index.html
( Very informational, good tips, Molers pictures, art work and much
more....
----- Original Message -----
From: <Bhls4301@AOL.COM>
To: <mol-cancer@lists.meds.com>
Sent: Monday, April 03, 2000 10:17 PM
Subject: [MOL] myleofibrosis
> COULD YOU EXPLAIN TO ME WHAT MYLEOFIBROSIS IS?
> AND WHAT THE MEDICATION OF BUSULFAM DOES FOR YOU?
> ------------------------------------------------------------------------
> This is an automatically-generated notice. If you'd like to be removed
> from the mailing list, please visit the Medicine-On-Line Discussion Forum
> at <http://www.meds.com/con_faq.html>, or send an email message to:
> majordomo@lists.meds.com
> with the subject line blank and the body of the message containing the
line:
> unsubscribe mol-cancer your-email-address
> where the phrase your-email-address is replaced with your actual email
> address.
> ------------------------------------------------------------------------
>
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
